2JMN
NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures
「1LNP」から置き換えられました 「1VKS」から置き換えられました2JMN の概要
| エントリーDOI | 10.2210/pdb2jmn/pdb |
| 関連するPDBエントリー | 2H67 |
| 分子名称 | Insulin A chain, Insulin B chain (2 entities in total) |
| 機能のキーワード | hormone, human insulin, mutant, hormone-growth factor complex, hormone/growth factor |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| 細胞内の位置 | Secreted: P01308 P01308 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 5794.59 |
| 構造登録者 | Hua, Q.X.,Hu, S.Q.,Frank, B.H.,Jia, W.H.,Chu, Y.C.,Wang, S.H.,Burke, G.T.,Katsoyannis, P.G.,Weiss, M.A. (登録日: 2006-11-21, 公開日: 2006-12-05, 最終更新日: 2024-10-30) |
| 主引用文献 | Hua, Q.X.,Hu, S.Q.,Frank, B.H.,Jia, W.,Chu, Y.C.,Wang, S.H.,Burke, G.T.,Katsoyannis, P.G.,Weiss, M.A. Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue. J.Mol.Biol., 264:390-403, 1996 Cited by PubMed Abstract: Functional surfaces of a protein are often mapped by combination of X-ray crystallography and mutagenesis. Such studies of insulin have yielded paradoxical results, suggesting that the native state is inactive and reorganizes on receptor binding. Of particular interest is the N-terminal alpha-helix of the A-chain. Does this segment function as an alpha-helix or reorganize as recently proposed in a prohormone-convertase complex? To correlate structure and function, we describe a mapping strategy based on protein design. The solution structure of an engineered monomer ([AspB10, LysB28, ProB29]-human insulin) is determined at neutral pH as a template for synthesis of a novel A-chain analogue. Designed by analogy to a protein-folding intermediate, the analogue lacks the A6-A11 disulphide bridge; the cysteine residues are replaced by serine. Its solution structure is remarkable for segmental unfolding of the N-terminal A-chain alpha-helix (A1 to A8) in an otherwise native subdomain. The structure demonstrates that the overall orientation of the A and B chains is consistent with reorganization of the A-chain's N-terminal segment. Nevertheless, the analogue's low biological activity suggests that this segment, a site of clinical mutation causing diabetes mellitus, functions as a preformed recognition alpha-helix. PubMed: 8951384DOI: 10.1006/jmbi.1996.0648 主引用文献が同じPDBエントリー |
| 実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)
をダウンロード






